CD4 and systemic lupus erythematosus: In summary, a transcriptome-wide ac4C modified panel of CD4+ T cells from HCs and SLE patients was illustrated to the best of our knowledge, for the first time, uncovering gene expression and SLE-related pathological pathways regulated by aberrated ac4C RNA modification.